Wimpey T L, Caudle R M, Chavkin C
Department of Pharmacology, University of Washington School of Medicine, Seattle 98195.
Neurosci Lett. 1990 Mar 14;110(3):349-55. doi: 10.1016/0304-3940(90)90872-7.
The mu-opioid agonist, [N-MePhe3,D-Pro4]morphiceptin (PL017), significantly decreased the conductance changes measured during both the early and late inhibitory postsynaptic potentials (IPSP) in CA1 pyramidal cells. Although the conductance change during the early IPSP was much larger than that during the late IPSP, the relative decrease in conductance caused by 1 microM PL017 was similar for both. Chronic morphine treatment of rats prior to hippocampal slice preparation resulted in a loss of PL017 (1 microM) effects on both the early and late IPSPs. These results suggest that opioids have an equal ability to alter both early and late IPSPs in the CA1, that these effects are equally sensitive to chronic morphine, and that these measurements are a sensitive means of determining opioid tolerance in the hippocampus.
μ-阿片受体激动剂[N-甲基苯丙氨酸3,D-脯氨酸4]吗啡脑啡肽(PL017)显著降低了在CA1锥体细胞早期和晚期抑制性突触后电位(IPSP)期间测量的电导变化。尽管早期IPSP期间的电导变化比晚期IPSP期间的大得多,但1μM PL017引起的电导相对降低对两者而言是相似的。在制备海马切片之前对大鼠进行慢性吗啡处理导致PL017(1μM)对早期和晚期IPSP的作用丧失。这些结果表明,阿片类药物改变CA1中早期和晚期IPSP的能力相同,这些作用对慢性吗啡同样敏感,并且这些测量是确定海马中阿片类药物耐受性的一种敏感方法。